I understand that many on this board simply want srpt to be better than bmrn, and that strategy may work out. But lets pretend drisa doesnt exist, what will the market want to see ? Is it 20%? More ? Less? Any opinions? The stuff i have read from fda is rather vague on dystrophin guidance.
The pros are cognizant of the market cap distinction you pointed out, but most brokers will pawn a secondary off on their clients who are not aware of that distinction nor are they probably aware of the last raise at 37 (altho srpt managers are well aware of that raise). Hence the importance of a strong looking chart. All imho
Pls describe what exactly the market or scientific experts will consider positive dystrophin readouts.....and what will they consider disappointing dystrophin readouts.......i know there has been concern in the past about a direct correlation between etep dose and amt of dystrophin production, so what will alleviate those concerns. Serious question......
Well they are not exactly lenders, they are investors, and many investors (including the pros) are sheep and the sheep love a strong looking chart. The last time they raised was 4/14 at 37? But with the progress srpt has made w fda not sure why they would raise at same price basically. I do think they raise in the next few months but think it will be north of 40. We shall see
They are a 21 bill market cap co that invested less than 1 bill in RNA. No biggy, the only reason i care about bmrn is the patent estate battle srpt might have w them
Agreed, if drug is approved srpt shouldnt need a buyout. They certainly wont need a big pharma salesforce to sell etep. If there is a buyout i can only see 2 reasons why: 1) the offer is ridiculously high. 2) srpt is having problems manufacturing enough etep....
And let me say one more thing, if a hedgy did get something from fda and it was negative (as opposed to very positive for etep/srpt) would the stock have recovered from 33 to 38 so quickly? We shall see....
It could very well be, and word leaked out selectively, hence AFs weird article that low and behold enabled plenty to buy at 33-34 instead of 37-38. That was not purely coincidence obviously
If you want to see the real deal imo look at SRPT, i recommended it here on May 19 w achn at 11 and SRPT at 22. Now they are at 7.7 and 38. Check out SRPT, do your own dd.....
bergycb • May 19, 2015 6:34 PM Flag
0users liked this postsusers disliked this posts0Reply
Dump your achn, buy some SRPT
Much more upside imo. Do your DD. SRPT is filing NDA and they will own all revenue. Achn nowhere near nda and would own tiny piece of revenue on off chance they get nda. Yet achn has the higher market cap. Dump achn buy SRPT. All imho
The people granting these patents and litigating them quite often have no clue. As you probably know, a selection patent is a common strategy in the industry to overcome RNAs claims that were apparently granted in too broad a manner. Etep should be a perfect case for a selection patent. Ive been waiting for this from SRPT but havent seen it yet. Otherwise not sure what im missing. No way RNA should invalidate etep imo
Clearly some shorts had to get out (or longs wanted in) and those articles and the stock just so happened to move from top of channel to bottom in a matter of a couple days. Now its going back to top of channel. But looking at this stock action and the timing of the articles, why did AF short buds have to get out (or conversely get in at bottom of channel) NOW? Ie what exaxtly new JUST went down that made them cover/buy..........?
My question is will shorts convert over to being long? When JCramer endorses SRPT i may take some profits, lol?
The Comical AF articles gave the shorts the opp to cover lower and the tipping point will be many of those covering shorts go long soon (or have started to do so last 2 trading days)....all imho
I seriously doubt it, AF and Cramer are just lackeys. But judging from the action (above ave volume) today there are still some big boys out there that are short this stock and also i would guess there are big boys out there who have missed this story up til now and want in lower. AF is just their tool. The stock was threatening to break out.....the big boys drove it to bottom of channel. It is what it is